Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Burkitt Lymphoma 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia 7 Lymphoma 6 Lymphoma, Follicular 5 Myelodysplastic Syndromes 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myeloid, Chronic-Phase 4 Leukemia, Myeloid, Acute 4 Leukemia, Myeloid, Accelerated Phase 4 Recurrence 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms, Plasma Cell 3 Multiple Myeloma 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Biphenotypic, Acute 3 Dendritic Cell Sarcoma, Interdigitating 3 Congenital Abnormalities 3 Blast Crisis 3 Sezary Syndrome 2 Sarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Mycosis Fungoides 2 Leukemia, Lymphocytic, Chronic, B-Cell 2

Interventions

tocilizumab 1 Methylprednisolone 1 Immunoglobulin G 1 Etanercept 1 Disulfides 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Pneumonia × Methylprednisolone × Clear all

NCT00421174 2021-11-01

BMTCTN0403

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed

37 enrolled 20 charts

Pneumonia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡